MILNER THERAPEUTICS SYMPOSIUM 2022
Tuesday 28th June
Cambridge, UK and Online
Milner Therapeutics Symposium 2022
Our Annual Symposium is an opportunity for scientists from academia and industry to discuss the latest academic and pre-clinical research and how it could be applied in the pharma and biotech industry to develop new treatments. It is our key networking event for Milner Therapeutics Institute partner organizations.
This year’s event will be held on Tuesday 28th June 2022, at West Road Concert Hall in Cambridge. This will be our first ever Hybrid Symposium, where we will welcome up to 500 delegates in person and also live-stream the event for those who are overseas or unable to attend.
Registration to the Symposium is free, and is open to academics and Milner affiliated companies only. Please do not register if your organisation is not currently affiliated with the Milner Therapeutics Institute. Instead, please email us at firstname.lastname@example.org to discuss eligibility.
REGISTER NOW »
Information for Attendees
The Milner Therapeutics Symposium 2022 will be our first hybrid symposium.
The in-person event will be held at West Road Concert Hall in Cambridge, and sessions will also be live-streamed to an online platform. Delegates will be asked to choose their ticket type (live or online) when registering for the Symposium.
Oncology · CNS therapeutics · Infectious Disease · Emerging technologies · Disease-relevant models in target discovery
Simon Boulton (Artios Pharma and The Francis Crick Institute), Lori Passmore (MRC Laboratory of Molecular Biology), Ravindra Gupta (Cambridge Institute of Therapeutic Immunology and Infectious Disease), Kristian Helin (Institute of Cancer Research), Giulia Biffi (CRUK Cambridge Institute, University of Cambridge), Matthias Zilbauer (Department of Paediatrics, University of Cambridge), Richard Hargreaves (Bristol Myers Squibb) and Andras Lakatos (Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge)
You can find out more about our speakers further down this page.
Shaping the future of interdisciplinary interactions
Chaired by Kristin-Anne Rutter (Cambridge University Health Partners)
Michael Anstey (Cambridge Innovation Capital) – Jamie Blundell (Institute for the Early Detection of Cancer, University of Cambridge) – Victoria Higgins (GlaxoSmithKline) – Andy Neely (University of Cambridge) – Jeroen Verheyen (Semarion)
We are keen to invite posters from both academia and industry, to be presented in person and/or digitally as part of our hybrid Symposium.
The deadline to submit poster abstracts is Friday, 3rd June. To submit a poster abstract, please click here.
If you’ve already submitted an abstract, we will contact you with a decision after the submission deadline.
Meet the Consortium Session
Registered attendees (academics and affiliated partners) can request a short meeting with our pharma companies in the Milner Therapeutics Consortium during the morning of the Symposium (10:30-11:45am). These will be short non-confidential discussions held with a Milner Board member from the company of interest, aimed at identifying collaborative opportunities.
Please complete this form only after you have registered. Attendees will be informed of meetings that have been confirmed ahead of the Symposium.
Affiliated Company Overview Videos
Milner Affiliated Companies are invited to submit an overview video for display on the online Symposium platform. Please email email@example.com to request the video specifications and upload link.
Please do not register if your organisation is not currently affiliated with the Milner Therapeutics Institute. Please email us at firstname.lastname@example.org to discuss eligibility.